272 related articles for article (PubMed ID: 26871294)
1. The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.
Kurihara H; Maruyama R; Ishiguro K; Kanno S; Yamamoto I; Ishigami K; Mitsuhashi K; Igarashi H; Ito M; Tanuma T; Sukawa Y; Okita K; Hasegawa T; Imai K; Yamamoto H; Shinomura Y; Nosho K
Oncotarget; 2016 Mar; 7(11):12704-17. PubMed ID: 26871294
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
Ito M; Mitsuhashi K; Igarashi H; Nosho K; Naito T; Yoshii S; Takahashi H; Fujita M; Sukawa Y; Yamamoto E; Takahashi T; Adachi Y; Nojima M; Sasaki Y; Tokino T; Baba Y; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Int J Cancer; 2014 Dec; 135(11):2507-15. PubMed ID: 24752710
[TBL] [Abstract][Full Text] [Related]
3. Serrated polyps and colorectal cancer: new pathway to malignancy.
Noffsinger AE
Annu Rev Pathol; 2009; 4():343-64. PubMed ID: 19400693
[TBL] [Abstract][Full Text] [Related]
4. Subtypes of the Type II Pit Pattern Reflect Distinct Molecular Subclasses in the Serrated Neoplastic Pathway.
Aoki H; Yamamoto E; Yamano HO; Sugai T; Kimura T; Tanaka Y; Matsushita HO; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Harada T; Sudo G; Eizuka M; Yorozu A; Kitajima H; Niinuma T; Kai M; Nojima M; Suzuki H; Nakase H
Dig Dis Sci; 2018 Jul; 63(7):1920-1928. PubMed ID: 29546645
[TBL] [Abstract][Full Text] [Related]
5. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity.
Srivastava A; Redston M; Farraye FA; Yantiss RK; Odze RD
Am J Surg Pathol; 2008 Feb; 32(2):296-303. PubMed ID: 18223333
[TBL] [Abstract][Full Text] [Related]
6. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
[TBL] [Abstract][Full Text] [Related]
7. Aspects of the Natural History of Sessile Serrated Adenomas/Polyps: Risk Indicators for Carcinogenesis in the Colorectal Mucosa?
Neary PM; Schwartzberg DM; Bora Cengiz T; Kalady MF; Church JM
Dis Colon Rectum; 2018 Dec; 61(12):1380-1385. PubMed ID: 30346367
[TBL] [Abstract][Full Text] [Related]
8. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points.
O'Brien MJ; Yang S; Mack C; Xu H; Huang CS; Mulcahy E; Amorosino M; Farraye FA
Am J Surg Pathol; 2006 Dec; 30(12):1491-501. PubMed ID: 17122504
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.
Yano Y; Konishi K; Yamochi T; Katagiri A; Nozawa H; Suzuki H; Toyota M; Kubota Y; Muramoto T; Kobayashi Y; Tojo M; Konda K; Makino R; Kaneko K; Yoshikawa N; Ota H; Imawari M
Am J Gastroenterol; 2011 Jul; 106(7):1351-8. PubMed ID: 21427714
[TBL] [Abstract][Full Text] [Related]
11. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps.
Kim YH; Kakar S; Cun L; Deng G; Kim YS
Int J Cancer; 2008 Dec; 123(11):2587-93. PubMed ID: 18798261
[TBL] [Abstract][Full Text] [Related]
12. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
[TBL] [Abstract][Full Text] [Related]
13. Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.
Nosho K; Igarashi H; Nojima M; Ito M; Maruyama R; Yoshii S; Naito T; Sukawa Y; Mikami M; Sumioka W; Yamamoto E; Kurokawa S; Adachi Y; Takahashi H; Okuda H; Kusumi T; Hosokawa M; Fujita M; Hasegawa T; Okita K; Hirata K; Suzuki H; Yamamoto H; Shinomura Y
Carcinogenesis; 2014 Apr; 35(4):776-83. PubMed ID: 24242331
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Signatures of Colonic Polyps on Screening and Histology.
Tsikitis VL; Potter A; Mori M; Buckmeier JA; Preece CR; Harrington CA; Bartley AN; Bhattacharyya AK; Hamilton SR; Lance MP; Thompson PA
Cancer Prev Res (Phila); 2016 Dec; 9(12):942-949. PubMed ID: 27658891
[TBL] [Abstract][Full Text] [Related]
15. The serrated pathway to colorectal carcinoma: current concepts and challenges.
Bettington M; Walker N; Clouston A; Brown I; Leggett B; Whitehall V
Histopathology; 2013 Feb; 62(3):367-86. PubMed ID: 23339363
[TBL] [Abstract][Full Text] [Related]
16. EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.
Yamamoto I; Nosho K; Kanno S; Igarashi H; Kurihara H; Ishigami K; Ishiguro K; Mitsuhashi K; Maruyama R; Koide H; Okuda H; Hasegawa T; Sukawa Y; Okita K; Takemasa I; Yamamoto H; Shinomura Y; Nakase H
Oncotarget; 2017 Mar; 8(11):17810-17818. PubMed ID: 28147317
[TBL] [Abstract][Full Text] [Related]
17. Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study.
Fujita K; Yamamoto H; Matsumoto T; Hirahashi M; Gushima M; Kishimoto J; Nishiyama K; Taguchi T; Yao T; Oda Y
Am J Surg Pathol; 2011 Feb; 35(2):295-304. PubMed ID: 21263251
[TBL] [Abstract][Full Text] [Related]
18. Three Pathways of Colonic Carcinogenesis in Rats.
Rubio CA
Anticancer Res; 2017 Jan; 37(1):15-20. PubMed ID: 28011469
[TBL] [Abstract][Full Text] [Related]
19. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J
Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389
[TBL] [Abstract][Full Text] [Related]
20. Pathologic features and biologic importance of colorectal serrated polyps.
Vakiani E; Yantiss RK
Adv Anat Pathol; 2009 Mar; 16(2):79-91. PubMed ID: 19550369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
